Rheumatoid Arthritis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age >=18 years; 2. Meeting the 2010 American College of Rheumatology/European Anti-Rheumatic League (ACR/EUR) criteria for rheumatoid arthritis; 3. Currently receiving disease-modifying anti-rheumatic drugs (DMARDs) with a treatment duration of >=3 months and stable therapeutic regimen; 4. No cognitive or communication impairments, capable of normal communication; 5. Informed consent obtained from patients, who voluntarily signed the informed consent form to participate in this study.
Exclusion criteria
Exclusion criteria: 1. Non-rheumatoid pain disorders: such as osteoarthritis, gout, herpes zoster, chronic low back pain, non-rheumatoid autoimmune diseases, and other conditions that may independently cause joint/systemic pain; 2. Presence of severe underlying diseases: including allergies, asthma, cancer, Alzheimer's disease, severe hepatic/renal insufficiency, heart failure, and severe cardiopulmonary diseases. 3. Acute/chronic pain events occurring within the past 1 month: including fractures, trauma, surgery, and other acute/chronic pain events unrelated to RA pain that may confound the assessment of intervention efficacy. 4. Patients with a dietary inflammation index result <0; 5. Pregnant or lactating women; 6. Patients who are clearly unable to adhere to an anti-inflammatory diet due to factors such as religious beliefs, taste preferences, or economic conditions (e.g., complete avoidance of fish or refusal of vegetables); 7. Patients who have followed a prescribed dietary plan within the past 1 month (any prescribed dietary plan provided by a nutritionist or any diet restricting certain types of food, such as fasting, ketogenic diet, vegetarian diet, etc.); 8. Patients currently participating in or who have participated in other relevant clinical studies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intensity in RA patients; | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall pain status in RA patients;Disease activity;Quality of life;Anxiety and depression status;Dietary adherence; | — |
Countries
China
Contacts
The First Hospital of Jilin University